Clinical Trial Update: Study of RP-6306 With FOLFIRI in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial of RP-6306 in combination with FOLFIRI for advanced solid tumors has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• RP-6306

Snippet

Sponsor: Debiopharm International SA | Conditions: Advanced Solid Tumor | Phase 1 | Status: TERMINATED | Results posted: 2025-08-20